Clinical Trial Update: Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tailored Hodgkin lymphoma therapy guided by early interim PET to inform treatment decisions, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Hodgkin Lymphoma | Phase 2 | Status: COMPLETED